title: Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration.
abstract: All-trans retinoic acid (RA) is a potent inducer of regeneration. Because the liver is the principal site for storage and bioactivation of vitamin A, the current study examines the effect of RA in mouse hepatocyte proliferation and liver regeneration. Mice that received a single dose of RA (25μg/g) by oral gavage developed hepatomegaly with increased number of Ki67-positive cells and induced expression of cell cycle genes in the liver. DNA binding data revealed that RA receptors retinoic acid receptor β (RARβ) and retinoid x receptor α (RXRα) bound to cell cycle genes Cdk1, Cdk2, Cyclin B, Cyclin E, and Cdc25a in mice with and without RA treatment. In addition, RA treatment induced novel binding of RARβ/RXRα to Cdk1, Cdk2, Cyclin D, and Cdk6 genes. All RARβ/RXRα binding sites contained AGGTCA-like motifs. RA treatment also promoted liver regeneration after partial hepatectomy (PH). RA signaling was implicated in normal liver regeneration as the mRNA levels of RARβ, Aldh1a2, Crabp1, and Crbp1 were all induced 1.5 days after PH during the active phase of hepatocyte proliferation. RA treatment prior to PH resulted in early up-regulation of RARβ, Aldh1a2, Crabp1, and Crbp1, which was accompanied by an early induction of cell cycle genes. Western blotting for RARβ, c-myc, Cyclin D, E, and A further supported the early induction of retinoid signal and cell proliferation by RA treatment. Taken together, our data suggest that RA may regulate cell cycle progression and accelerates liver regeneration. Such effect is associated with an early induction of RA signaling, which includes increased expression of the receptor, binding proteins, and processing enzyme for retinoids.
authors.affiliation: Department of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: huixinliu2012@gmail.com.
authors.forename: Hui-Xin
authors.initials: HX
authors.lastname: Liu
authors.affiliation: Department of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: Irene.ly@ucdmc.ucdavis.edu.
authors.forename: Irene
authors.initials: I
authors.lastname: Ly
authors.affiliation: Department of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: yinghu0821@gmail.com.
authors.forename: Ying
authors.initials: Y
authors.lastname: Hu
authors.affiliation: Department of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: yjywan@ucdavis.edu.
authors.forename: Yu-Jui Yvonne
authors.initials: YJ
authors.lastname: Wan
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects*; D018816:Genes, cdc / Q000235:genetics / Q000502:physiology*; D008115:Liver Regeneration / Q000187:drug effects*; D008297:Male; D051379:Mice; D011485:Protein Binding; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D012333:RNA, Messenger; D014212:Tretinoin
keywords: Hepatocyte; Nuclear receptor; Partial hepatectomy; Proliferation; Pubchem CID: 444795; Retinoic acid receptor
references.citation: Eur J Pharmacol. 2010 Sep 25;643(2-3):267-73
references.pmid: 20619257
references.citation: Adv Drug Deliv Rev. 2010 Oct 30;62(13):1285-98
references.pmid: 20654663
references.citation: Cancer Chemother Rep. 1971 Feb;55(1):53-8
references.pmid: 5121651
references.citation: J Natl Cancer Inst. 2001 Apr 18;93(8):605-18
references.pmid: 11309437
references.citation: Experientia. 1992 Apr 15;48(4):386-8
references.pmid: 1349864
references.citation: Nat Rev Drug Discov. 2007 Oct;6(10):793-810
references.pmid: 17906642
references.citation: Life Sci. 1996;58(11):PL211-216
references.pmid: 8786690
references.citation: Hepatology. 1998 Sep;28(3):727-37
references.pmid: 9731565
references.citation: BMC Bioinformatics. 2010 Aug 06;11:415
references.pmid: 20691053
references.citation: Biochem Pharmacol. 2013 Apr 1;85(7):1007-17
references.pmid: 23396089
references.citation: J Natl Cancer Inst. 1996 Nov 6;88(21):1550-9
references.pmid: 8901853
references.citation: Development. 1994 Jul;120(7):1861-72
references.pmid: 7924993
references.citation: J Lipid Res. 2013 Apr;54(4):893-908
references.pmid: 23349206
references.citation: J Cell Physiol. 1993 Oct;157(1):104-9
references.pmid: 8408229
references.citation: Genome Biol. 2009;10(3):R25
references.pmid: 19261174
references.citation: J Biol Chem. 1996 Oct 11;271(41):25524-32
references.pmid: 8810324
references.citation: Biochem Biophys Res Commun. 1993 Mar 15;191(2):675-80
references.pmid: 8461021
references.citation: Biochim Biophys Acta. 1999 Jul 8;1450(3):308-19
references.pmid: 10395942
references.citation: Hum Mol Genet. 2001 Apr;10(7):699-703
references.pmid: 11257102
references.citation: Acta Biomed. 2007 Dec;78(3):204-9
references.pmid: 18330080
references.citation: Carcinogenesis. 2004 Nov;25(11):2061-6
references.pmid: 15231690
references.citation: Hepatology. 2008 Apr;47(4):1277-87
references.pmid: 18167061
references.citation: J Biol Chem. 1999 Sep 17;274(38):26783-8
references.pmid: 10480883
references.citation: J Nutr. 2004 May;134(5):1139-44
references.pmid: 15113960
references.citation: Hepatology. 2006 Feb;43(2 Suppl 1):S45-53
references.pmid: 16447274
references.citation: PLoS One. 2013 Jun 18;8(6):e65644
references.pmid: 23823620
references.citation: J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70
references.pmid: 8901854
references.citation: Mol Biol Cell. 2013 Dec;24(23):3634-50
references.pmid: 24109597
references.citation: Dev Dyn. 2003 Feb;226(2):237-44
references.pmid: 12557202
references.citation: Clin Cancer Res. 2002 Sep;8(9):2835-42
references.pmid: 12231524
references.citation: J Gastroenterol Hepatol. 2006 Nov;21(11):1726-30
references.pmid: 16984597
references.citation: Nature. 1982 Feb 25;295(5851):672-5
references.pmid: 7057925
references.citation: N Engl J Med. 1996 May 2;334(18):1150-5
references.pmid: 8602180
references.citation: J Lipid Res. 1981 Aug;22(6):899-904
references.pmid: 6268726
references.citation: PLoS One. 2012;7(11):e50013
references.pmid: 23166811
references.citation: J Surg Res. 2013 Apr;180(2):e99-e106
references.pmid: 22560855
references.citation: PLoS One. 2013 Dec 19;8(12):e82872
references.pmid: 24367566
references.citation: Cell Biochem Funct. 2008 Apr;26(3):359-65
references.pmid: 18008394
references.citation: Genome Biol. 2008;9(9):R137
references.pmid: 18798982
references.citation: Mol Carcinog. 1991;4(2):138-44
references.pmid: 1710463
references.citation: Oncol Rep. 2013 Jun;29(6):2318-24
references.pmid: 23525508
references.citation: N Engl J Med. 1994 Apr 14;330(15):1029-35
references.pmid: 8127329
references.citation: Blood. 1995 May 15;85(10):2643-53
references.pmid: 7742522
references.citation: J Biol Chem. 2001 Jan 26;276(4):2440-50
references.pmid: 11036068
references.citation: Nat Cell Biol. 2011 Aug 14;13(9):1146-52
references.pmid: 21841792
references.citation: Am J Pathol. 2010 Feb;176(2):733-43
references.pmid: 20035057
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16881-6
references.pmid: 12482952
references.citation: Cancer Lett. 1998 Feb 27;124(2):205-11
references.pmid: 9500212
references.citation: Haematologica. 2000 May;85(5):551-2
references.pmid: 10800178
references.citation: J Natl Cancer Inst. 2006 Apr 5;98(7):441-50
references.pmid: 16595780
references.citation: Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):774-9
references.pmid: 21187396
references.citation: Biomed Res. 2006 Apr;27(2):75-80
references.pmid: 16707846
references.citation: Biochem Pharmacol. 2007 Feb 15;73(4):586-96
references.pmid: 17126819
references.citation: Nat Rev Cancer. 2001 Dec;1(3):181-93
references.pmid: 11902573
references.citation: Breast Cancer Res Treat. 1998 Apr;48(3):265-71
references.pmid: 9598873